ZACHARY FISK: Open Payments
NPI 1992931711 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 6 payments from 3 companies in 2025. Trend: 2023 $404 · 2024 $220 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $84 |
| Merz Pharmaceuticals, LLC | 1 | $47 |
| SPR Therapeutics, Inc | 1 | $40 |
Products named: Xeomin, QULIPTA, SPRINT PNS System, BOTOX, UBRELVY.
Industry payments across WA — which companies pay providers there.
